Forbes.com interviews CEO of GeckoSystems

GeckoSystems Intl. Corp. (PINKSHEETS: GCKO) (http://www.geckosystems.com/) announced today that they are very pleased with the recent press coverage they have received from Forbes.com and other notable online authors. GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

"All of us here at GeckoSystems are excited about Courtney Boyd Myers' article titled, 'Silicon Stethoscopes: Telepresence technologies and robotics promise another way to ease future health care burdens.' (Shortcut: http://tinyurl.com/lz2ecc) Myers is a Forbes.com senior journalist covering AI and robotics developments. She is the editor of 'The AI Report, the Past, Present and Future of AI.' We are very pleased and appreciative to receive this kind of recognition for our many years of hard work," stated Martin Spencer, President/CEO, GeckoSystems.

Many in the U.S. may mistakenly believe that the Japanese are world leaders in personal robot development. However, this is not the case. In the last ten years, the Japanese government has granted over $100M in R&D funding amongst their leading international manufacturers for the development of eldercare personal companion robots, but still have no viable products developed. An excellent illustration of this is Matsushita's recent failure when they attempted to sell their "Wakamaru" personal companion robot. Many observers believe it lacked sufficient cost effective utility that prevented it from being perceived as a "value" by the Japanese consumer. It has been taken off the market.

As indicated in the Forbes article, due to the sufficiency and cost effective robustness of GeckoSystems' first product, the CareBot™, near term in-home evaluation trials are anticipated.

"In the U.S., we project the available market size in dollars for cost effective, utilitarian, multitasking eldercare personal companion robots in 2010 to be $74.0B, in 2011 to be $77B, in 2012 to be $80B, in 2013 to be $83.3B, and in 2014 to be $86.6B. With market penetrations of 0.03% in 2010, 0.06% in 2011, 0.22% in 2012, 0.53% in 2013, and 0.81% in 2014, we will anticipate sales, from this consumer market segment, only, of $22.0M, $44.0M, $176M, $440.2M, and $704.3M, respectively. We expect these sales despite -- and perhaps because of -- the present recession due to pent-up demand for significant cost reduction in eldercare expenses," concluded Spencer.

Other recent online articles:

"Personal Robots to Monitor Elderly Vital Signs" - June 16, 2009 By C. G. Masi http://cgmasi.com/eyeontechnology/2009/06/personal-robots-to-monitor-elderly-vital-signs.html

"The Robots Have Dawned: Meet The CareBot™" - June 28, 2009 By Ira Rosofsky, Ph.D http://www.psychologytoday.com/blog/adventures-in-old-age/200906/the-robots-have-dawned-meet-the-carebot

Journalists are encouraged to contact Mr. Spencer regarding the progress of GeckoSystems and potential attendance at the upcoming invitation only "Mobile Robots in Motion" Conference. They may submit their request at their website or call 678-413-1640.

Source:

GeckoSystems Intl. Corp.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Adopting a healthy lifestyle boosts life expectancy and cuts healthcare costs